Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Huntington’s Disease Treatment Market, by Drug Type
1.4.2 Europe Huntington’s Disease Treatment Market, by Distribution Channel
1.4.3 Europe Huntington’s Disease Treatment Market, by Age
1.4.4 Europe Huntington’s Disease Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Huntington’s Disease Treatment Market by Drug Type
4.1 Europe Approved Drugs Market by Country
4.2 Europe Huntington’s Disease Treatment Market by Approved Drugs Type
4.2.1 Europe Tetrabenazine Market by Country
4.2.2 Europe Deutetrabenazine Market by Country
4.3 Europe Offlabel Drugs Market by Country
Chapter 5. Europe Huntington’s Disease Treatment Market by Distribution Channel
5.1 Europe Hospital Pharmacies Market by Country
5.2 Europe Drug Store & Retail Pharmacies Market by Country
5.3 Europe Online Pharmacies Market by Country
Chapter 6. Europe Huntington’s Disease Treatment Market by Age
6.1 Europe Below 50 years Market by Country
6.2 Europe Above 50 years Market by Country
Chapter 7. Europe Huntington’s Disease Treatment Market by Country
7.1 Germany Huntington’s Disease Treatment Market
7.1.1 Germany Huntington’s Disease Treatment Market by Drug Type
7.1.1.1 Germany Huntington’s Disease Treatment Market by Approved Drugs Type
7.1.2 Germany Huntington’s Disease Treatment Market by Distribution Channel
7.1.3 Germany Huntington’s Disease Treatment Market by Age
7.2 UK Huntington’s Disease Treatment Market
7.2.1 UK Huntington’s Disease Treatment Market by Drug Type
7.2.1.1 UK Huntington’s Disease Treatment Market by Approved Drugs Type
7.2.2 UK Huntington’s Disease Treatment Market by Distribution Channel
7.2.3 UK Huntington’s Disease Treatment Market by Age
7.3 France Huntington’s Disease Treatment Market
7.3.1 France Huntington’s Disease Treatment Market by Drug Type
7.3.1.1 France Huntington’s Disease Treatment Market by Approved Drugs Type
7.3.2 France Huntington’s Disease Treatment Market by Distribution Channel
7.3.3 France Huntington’s Disease Treatment Market by Age
7.4 Russia Huntington’s Disease Treatment Market
7.4.1 Russia Huntington’s Disease Treatment Market by Drug Type
7.4.1.1 Russia Huntington’s Disease Treatment Market by Approved Drugs Type
7.4.2 Russia Huntington’s Disease Treatment Market by Distribution Channel
7.4.3 Russia Huntington’s Disease Treatment Market by Age
7.5 Spain Huntington’s Disease Treatment Market
7.5.1 Spain Huntington’s Disease Treatment Market by Drug Type
7.5.1.1 Spain Huntington’s Disease Treatment Market by Approved Drugs Type
7.5.2 Spain Huntington’s Disease Treatment Market by Distribution Channel
7.5.3 Spain Huntington’s Disease Treatment Market by Age
7.6 Italy Huntington’s Disease Treatment Market
7.6.1 Italy Huntington’s Disease Treatment Market by Drug Type
7.6.1.1 Italy Huntington’s Disease Treatment Market by Approved Drugs Type
7.6.2 Italy Huntington’s Disease Treatment Market by Distribution Channel
7.6.3 Italy Huntington’s Disease Treatment Market by Age
7.7 Rest of Europe Huntington’s Disease Treatment Market
7.7.1 Rest of Europe Huntington’s Disease Treatment Market by Drug Type
7.7.1.1 Rest of Europe Huntington’s Disease Treatment Market by Approved Drugs Type
7.7.2 Rest of Europe Huntington’s Disease Treatment Market by Distribution Channel
7.7.3 Rest of Europe Huntington’s Disease Treatment Market by Age
Chapter 8. Company Profiles
8.1 Dr. Reddy’s Laboratories Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Sun Pharmaceutical Industries Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Hikma Pharmaceuticals PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
8.5.1 Company Overview
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Bausch Health Companies, Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Neurocrine Biosciences Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expenses
8.9 Pfizer, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional & Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. F. Hoffmann-La Roche Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Unique Offerings 